Manufacturing Vaccines in Adherent Cell Lines Using Disposable Multi-tray Bioreactors - By allowing a single system to be used from laboratory- to commercial-scale, multi-tray bioreactors can facilita

ADVERTISEMENT

Manufacturing Vaccines in Adherent Cell Lines Using Disposable Multi-tray Bioreactors
By allowing a single system to be used from laboratory- to commercial-scale, multi-tray bioreactors can facilitate scale up and accelerate vaccine development.


BioPharm International


References:

1 Cesano A, Visonneau S, Jeglum KA, Owen J, Wilkinson K, Carner K, et al. Phase i clinical trial with a human major histocompatibility complex nonrestricted cytotoxic t-cell line (tall-104) in dogs with advanced tumors. Cancer Res. 1996; 56:3021–3029.

2. Schwander E, Ramusen, H. Manufacturing of lots of human T lymphocytes for cell therapy: A new process based on disposable bioreactors. Gen Eng News. 2005 Apr 15; 25(8).

3. Schlenke P, et al. Serum-free transient expression of antibodies using 40 tray cell factories. Poster. Laupheim, Germany: Renschler Biotechnologie Gmbh.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here